Stoke Therapeutics, Inc.

NASDAQ:STOK

13.27 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -104.699-101.067-85.805-52.243-32.325-12.521-5.558
Depreciation & Amortization 4.7291.5460.9740.8880.450.2140.113
Deferred Income Tax 3.20800.1720.003000
Stock Based Compensation 25.25722.85416.455.7681.9220.240.026
Change In Working Capital -6.0343.0230.0462.325-1.1051.0930.031
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -3.2080.1212.8975.2030.8911.7350.1
Other Working Capital -2.82242.902-2.851-2.878-1.9961.0930.031
Other Non Cash Items -3.5321.7781.2561.0380.0030.010.004
Operating Cash Flow -81.067-31.866-66.907-42.221-31.055-10.964-5.384
Investing Activities:
Investments In Property Plant And Equipment -1.616-3.962-1.2-1.05-1.635-0.935-0.113
Acquisitions Net 045.34475.22600.0010.010
Purchases Of Investments 0-201.32-87.2260000
Sales Maturities Of Investments 107.562159.4120000
Other Investing Activites 107.562-45.344-75.22600.0010.010
Investing Cash Flow 105.946-45.882-76.426-1.05-1.634-0.925-0.113
Financing Activities:
Debt Repayment 000000-3
Common Stock Issued 53.00746.4081.286105.398151.912115.6412.975
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 53.00746.409-0.0022.71-2.15115.6395.974
Financing Cash Flow 53.00746.4091.284108.108149.762115.6395.974
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 77.886-31.339-142.04964.837117.073103.750.477
Cash At End Of Period 191.442114.125145.464287.513222.676105.6031.853